Tempus AI (NASDAQ:TEM) Stock Price Up 6.7% – Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares traded up 6.7% on Friday . The stock traded as high as $62.15 and last traded at $61.05. Approximately 9,209,341 shares traded hands during mid-day trading, a decline of 6% from the average daily volume of 9,842,106 shares. The stock had previously closed at $57.19.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Loop Capital reduced their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Wolfe Research assumed coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price on the stock. Bank of America raised their price target on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Guggenheim started coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective on the stock. Finally, Piper Sandler reissued a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Tempus AI Trading Up 1.8 %

The business has a 50 day simple moving average of $44.21 and a 200 day simple moving average of $48.03. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insiders Place Their Bets

In other news, CEO Eric P. Lefkofsky sold 85,788 shares of Tempus AI stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $53.39, for a total transaction of $4,580,221.32. Following the sale, the chief executive officer now owns 5,771,787 shares of the company’s stock, valued at approximately $308,155,707.93. This trade represents a 1.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Bradley A. Keywell sold 265,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the sale, the insider now owns 15,218,365 shares of the company’s stock, valued at $534,164,611.50. The trade was a 1.71 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,862,758 shares of company stock valued at $79,585,675 over the last three months.

Institutional Investors Weigh In On Tempus AI

Several large investors have recently bought and sold shares of the company. First Horizon Advisors Inc. bought a new position in shares of Tempus AI during the third quarter worth about $30,000. FNY Investment Advisers LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $67,000. Vestor Capital LLC acquired a new position in Tempus AI during the third quarter valued at approximately $153,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI in the fourth quarter valued at approximately $178,000. Finally, Stifel Financial Corp acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $218,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.